Latest filingSep 03, 2026Most recent Form 4
MRNA
Moderna, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$48.5M1 sells
Net open-market-$48.5M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period24transactions
- M · Option exercise · dominant16 · 67%
- F · Tax withholding7 · 29%
- S · Open-market sells1 · 4%
Activity by reported role
A joint filing can contribute to multiple roles24transactions
- CLO · dominant12 · 50%
- Chief financial officer9 · 38%
- PRES3 · 13%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeKlinger Shannon ThymeCommon Stock · Direct
77,600Sep 01, 2026
Mock James MCommon Stock · Direct
69,479Sep 01, 2026
Mock James MRestricted Stock Units · Direct
24,755Sep 01, 2026
Klinger Shannon ThymeRestricted Stock Units · Direct
21,661Sep 01, 2026
Hoge StephenCommon Stock · Direct
1,494,188Sep 01, 2026
Hoge StephenRestricted Stock Units · Direct
92,828Sep 01, 2026
Klinger Shannon ThymeStock Option (Right to Buy) · Direct
34,716Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Top insiders
By absolute net value across the selected period- KT-$485.8k
Recent filing activity
Most recent 1 transactions · color = transaction code- SSell09/03-$48.5MSEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
MRNA transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | Klinger Shannon Thyme | CLO | sale10b5-1 | 3.47k | -$48.5M | S | — | 0.0% | 09/03 | 09/01 |
Moderna, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Moderna, Inc.?
Klinger Shannon Thyme, Mock James M, Hoge Stephen.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Klinger Shannon Thyme reported a sale on Sep 01, 2026 valued at $48.5M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $485,766.45. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.